MARC record from Internet Archive

LEADER: 06538cam 2200841Ii 4500
001 ocn890689878
003 OCoLC
005 20200803000528.0
008 140917s2014 ne a ob 001 0 eng d
006 m o d
007 cr cnu---unuuu
040 $aGW5XE$beng$erda$epn$cGW5XE$dN$T$dYDXCP$dIDEBK$dOCLCQ$dE7B$dCOO$dEBLCP$dOCLCF$dMMU$dZ5A$dESU$dOCLCQ$dIOG$dCEF$dU3W$dWYU$dOCLCO$dOCLCA$dYOU$dMERER$dOCLCQ$dOCLCO$dOCLCQ$dOCLCA$dOCLCQ
019 $a893684274
020 $a9789401793254$q(electronic bk.)
020 $a9401793255$q(electronic bk.)
020 $z9789401793247
020 $z9401793247
024 7 $a10.1007/978-94-017-9325-4$2doi
035 $a(OCoLC)890689878$z(OCoLC)893684274
050 4 $aRD651
060 4 $aQZ 202
072 7 $aHEA$x039000$2bisacsh
072 7 $aMED$x014000$2bisacsh
072 7 $aMED$x022000$2bisacsh
072 7 $aMED$x112000$2bisacsh
072 7 $aMED$x045000$2bisacsh
082 04 $a616.994$223
245 00 $aTumor dormancy, quiescence, and senescence.$nVolume 3,$pAging, cancer, and noncancer pathologies /$cedited by M.A. Hayat.
246 30 $aAging, cancer, and noncancer pathologies
264 1 $aDordrecht :$bSpringer,$c2014.
300 $a1 online resource (xxvi, 144 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aTumor dormancy and cellular quiescence and senescence, aging, cancer, and noncancer pathologies ;$vvolume 3
504 $aIncludes bibliographical references and index.
588 0 $aOnline resource; title from PDF title page (SpringerLink, viewed Sep. 17, 2014).
505 0 $aPreface -- Part I: General applications. Active, dormant, or on the path to elimination: what does a senescent cell do?- Hypoxia and tumor dormancy: can the two tango?- Progeriod syndromes: role of accelerated fibroblast senescence and p38 activation -- Induction of cancer cells senescence: role of caffeic acid 3,4-dihydroxy-phenethyl ester -- Part II: Role in breast cancer. Various factors contributing to tumor dormancy: therapeutic implications in breast cancer -- Progression of hormone-dependent mammary tumors after dormancy: role of wnt pathway -- Part III: Role in ovarian cancer. Chemoresistance, dormancy and recurrence in platinum drug therapy of ovarian cancers -- The role of angiogenesis, growth arrest and autophagy in human ovarian cancer xenograft models for tumor dormancy -- Part IV: Role in leukemia. Regulation of the promyelocytic leukemia protein and its role in premature senescence -- Part V: Role in cardiovascular disease. Cardiac senescence and autophagy -- Index.
520 $aThis third volume in the series Tumor Dormancy, Quiescence, and Senescence discusses the role of tumor dormancy and senescence in a number of diseases, including breast cancer, ovarian cancer, and leukemia. The contents are organized under five subheadings: General Applications, Role in Breast Cancer, Role in Ovarian Cancer, Role in Leukemia and Role in Cardiovascular Disease. The first section includes basic information on the definition of dormancy, how cells become senescent, and what they do, along with an appraisal of the current state of research on dormancy. Section Two explores dormancy in breast cancer, including the progression of hormone-dependent mammary tumors after dormancy. Section Three details the resistance of Type II ovarian tumors, in which the resistant tumor cell population persists after chemotherapy in a state of dormancy, with recurrent tumors arising upon transformation of such dormant cells back to malignant growth. This section explains how lineage, histological subtypes, and grade influence the differential response of ovarian cancer resistance to platinum drugs. The fourth section explores leukemia, discussing regulation of the promyelocytic leukemia protein and its role in premature senescence. The final section explores the role of senescence and autophagy in age-related cardiovascular diseases, and the observation that autophagy seems to retard cardiac senescence. Like the two preceding volumes in the series, Volume 3 stands out for its comprehensive approach, its roster of some 26 expert contributors representing seven different countries and its up-to-date review of leading-edge technology and methods.
650 0 $aTumors.
650 2 $aNeoplasms.
650 7 $aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
650 7 $aMEDICAL$xClinical Medicine.$2bisacsh
650 7 $aMEDICAL$xDiseases.$2bisacsh
650 7 $aMEDICAL$xEvidence-Based Medicine.$2bisacsh
650 7 $aMEDICAL$xInternal Medicine.$2bisacsh
650 7 $aTumors.$2fast$0(OCoLC)fst01158759
655 4 $aElectronic books.
700 1 $aHayat, M. A.,$d1940-$eeditor.
776 08 $iPrint version:$tTumor dormancy, quiescence, and senescence.$dDordrecht : Springer, 2013-$z9789400759572$w(DLC) 2013931982$w(OCoLC)857718953
830 0 $aTumor dormancy and cellular quiescence and senescence ;$v3.
856 40 $3ProQuest Ebook Central$uhttp://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=1967241
856 40 $3ebrary$uhttp://site.ebrary.com/id/10930400
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=846204
856 40 $3MyiLibrary$uhttp://www.myilibrary.com?id=767127
856 40 $3Scholars Portal$uhttp://books.scholarsportal.info/viewdoc.html?id=/ebooks/ebooks3/springer/2014-12-11/1/9789401793254
856 40 $3Scholars Portal Books$uhttp://www.library.yorku.ca/e/resolver/id/2594393
856 40 $3SpringerLink$uhttps://doi.org/10.1007/978-94-017-9325-4
856 40 $3SpringerLink$uhttp://link.springer.com/openurl?genre=book&isbn=978-94-017-9324-7
856 40 $3SpringerLink$uhttp://link.springer.com/10.1007/978-94-017-9325-4
856 40 $3SpringerLink$uhttp://www.library.yorku.ca/e/resolver/id/2594394
856 40 $uhttps://0-link-springer-com.pugwash.lib.warwick.ac.uk/10.1007/978-94-017-9325-4$zConnect to Springer e-book
938 $aProQuest Ebook Central$bEBLB$nEBL1967241
938 $aebrary$bEBRY$nebr10930400
938 $aEBSCOhost$bEBSC$n846204
938 $aProQuest MyiLibrary Digital eBook Collection$bIDEB$ncis29781070
938 $aYBP Library Services$bYANK$n12100497
029 1 $aAU@$b000057875693
029 1 $aAU@$b000058376742
029 1 $aDEBBG$bBV043892009
029 1 $aNZ1$b15900314
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 303 OTHER HOLDINGS